🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The SPEED study is a randomized, crossover pilot study evaluating the pharm...
Status
Completed
Location
Stanford University
Start Date
2025-10-28
Trial ID
NCT07090824
The purpose of this study is to determine the safety of and immune response...
Status
Completed
Location
Alabama Vaccine CRS
Start Date
2006-02
Trial ID
NCT00270218
Treatments Being Tested
The epidermal growth factor receptor (EGFR) is both oncogene and prognostic...
Status
Completed
Location
UPMC Presbyterian
Start Date
2015-08
Trial ID
NCT02277197
Treatments Being Tested
This study in healthy volunteers will provide a basis for evaluation of inh...
Status
Not Yet Recruiting
Location
Celerion
Start Date
2026-10
Trial ID
NCT07644195
Treatments Being Tested
REPAIR-MS is a single-center open label, sequential group, investigator and...
Status
Completed
Location
University of Texas Southwestern
Start Date
2019-12-19
Trial ID
NCT03993171
Treatments Being Tested
This is a phase 2,prospective double-blind, randomized, parallel-group stud...
Status
Completed
Location
Clinical Trial Center, CTC
Start Date
2021-11-08
Trial ID
NCT05178134
This will be a randomized, open-label pilot study of 70 patients with and w...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2023-06-02
Trial ID
NCT05528588
Treatments Being Tested
This Phase II clinical study is to test safety and efficacy of BT061 agains...
Status
Completed
Location
Dermatologic Clinic
Start Date
2010-02
Trial ID
NCT01072383
Treatments Being Tested
The study aims to evaluate the efficacy, improvement from baseline in Eczem...
Status
Unknown
Location
Zenith Research
Start Date
2020-03-10
Trial ID
NCT04413942
This study is a Phase I/II, double-blind, placebo-controlled trial investig...
Status
Completed
Location
XBiotech Investigative Site
Start Date
2015-05
Trial ID
NCT02357966
Treatments Being Tested